Assignee
QAAM PHARMACEUTICALS LLC
US·4 granted patents·1 pending application·0 citations·filing 2016–2024
Top patents by PatentIndex Score
5 records- 0174US2024423965A1Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disordersQAAM PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0273US11419850B2Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseasesQAAM PHARMACEUTICALS LLC·Filed 2019·Granted Aug 23, 2022·0 cites·39 claims
- 0366US12109202B2Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disordersQAAM PHARMACEUTICALS LLC·Filed 2021·Granted Oct 8, 2024·0 cites·5 claims
- 0464US10376493B2Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseasesQAAM PHARMACEUTICALS LLC·Filed 2016·Granted Aug 13, 2019·0 cites·10 claims
- 0542US10519109B2Glycopyrronium fatty acid salts and methods of making sameQAAM PHARMACEUTICALS LLC·Filed 2016·Granted Dec 31, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when QAAM PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →